Literature DB >> 17009252

In patients undergoing neuromodulation for intractable urge incontinence a reduction in 24-hr pad weight after the initial test stimulation best predicts long-term patient satisfaction.

Raymond T Foster1, Elizabeth J Anoia, George D Webster, Cindy L Amundsen.   

Abstract

AIMS: To evaluate long-term patient satisfaction of sacral neuromodulation and to correlate satisfaction with incontinence parameters.
METHODS: Patients at least 1-year remote from sacral neuromodulation were mailed a questionnaire to evaluate satisfaction and assess incontinence symptoms.
RESULTS: Fifty-two patients were consecutively enrolled in the study. Forty-nine questionnaires (94.2%) were returned. The average interval between implantation and questionnaire completion was 27.2 (range 12-52) months. 83.7% of respondents were satisfied and 79.6% of patients would "do it all over again." Compared to dissatisfied subjects during test stimulation, the satisfied patients had a significant decrease in 24-hr pad weight (84.5% vs. 60.6%, P = 0.002) but did not differ in daily pad usage (4.5 fewer pads per day vs. 3.4, P = 0.190). At long-term follow-up, satisfied patients noted significantly greater improvement in their Incontinence Impact Questionnaire score versus dissatisfied patients (mean improvement 53 vs. 10 points, P = 0.0003). Using multiple logistic regression, change in 24-hr pad weight, but not change in average daily pad usage, was correlated with long-term satisfaction.
CONCLUSIONS: Eighty-four percent of patients were satisfied with sacral neuromodulation at a mean of 27 months. An 84.5% reduction in 24-hr pad weight correlated with long-term patient satisfaction. In addition to lack of efficacy, device pain was a contributing factor to dissatisfaction. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17009252     DOI: 10.1002/nau.20330

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  10 in total

Review 1.  A systematic review of clinical studies of electrical stimulation for treatment of lower urinary tract dysfunction.

Authors:  Ash K Monga; Michael R Tracey; Jeyakumar Subbaroyan
Journal:  Int Urogynecol J       Date:  2012-03-17       Impact factor: 2.894

2.  Surgical options for drug-refractory overactive bladder patients.

Authors:  Jonathan S Starkman; Christopher P Smith; David R Staskin
Journal:  Rev Urol       Date:  2010

3.  Impact of staged InterStim implantation on the postoperative activities of daily living and pain.

Authors:  Amie Kawasaki; John P Judd; Nazema Y Siddiqui; Jennifer M Wu; Cindy L Amundsen
Journal:  Int Urogynecol J       Date:  2012-11-17       Impact factor: 2.894

4.  The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA trial.

Authors:  Cindy L Amundsen; Holly E Richter; Shawn Menefee; Sandip Vasavada; David D Rahn; Kim Kenton; Heidi S Harvie; Dennis Wallace; Susie Meikle
Journal:  Contemp Clin Trials       Date:  2014-01-30       Impact factor: 2.226

5.  [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].

Authors:  M R Hoda; P Fornara
Journal:  Urologe A       Date:  2010-10       Impact factor: 0.639

6.  Neuromodulation versus medication for overactive bladder: the case for early intervention.

Authors:  Frank N Burks; Kenneth M Peters
Journal:  Curr Urol Rep       Date:  2009-09       Impact factor: 3.092

Review 7.  [Second-line therapy of idiopathic detrusor overactivity. Sacral neuromodulation and botulinum toxin A].

Authors:  B Amend; D Castro-Diaz; E Chartier-Kastler; D De Ridder; K Everaert; M Spinelli; P van Kereebroeck; K-D Sievert
Journal:  Urologe A       Date:  2010-02       Impact factor: 0.639

8.  Sacral neuromodulation and refractory overactive bladder: an emerging tool for an old problem.

Authors:  Mai Ahmed Banakhar; Tariq Al-Shaiji; Magdy Hassouna
Journal:  Ther Adv Urol       Date:  2012-08

9.  Pelvic electrical neuromodulation for the treatment of overactive bladder symptoms.

Authors:  Tariq F Al-Shaiji; Mai Banakhar; Magdy M Hassouna
Journal:  Adv Urol       Date:  2011-05-14

Review 10.  Current and future techniques of neuromodulation for bladder dysfunction.

Authors:  Neil D Sherman; Cindy L Amundsen
Journal:  Curr Urol Rep       Date:  2007-11       Impact factor: 2.862

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.